Active	Status	Sponsor type	Region	Phase	Filter
1 Active 1 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Ad-SGE-REIC / Momotaro-Gene
NCT04013334: MTG201 Plus Nivolumab in Patients With Relapsed Pleural Mesothelioma	Active, not recruiting	2	12	US	MTG201, Ad-SGE-REIC/Dkk-3, Nivolumab Injection [Opdivo], Opdivo	Momotaro-Gene Inc., Baylor College of Medicine, Synteract, Inc.	Malignant Pleural Mesothelioma	12/22	01/23